FDA – Page 5 – medicarereport.org

Thursday, May 22, 2025

Latest:

FDA Health Care - General Veterans Benefits

Eileen Cook January 12, 2024January 12, 2024 Adstiladrin, cancer, FDA, Veterans, Veterans Health care

New gene therapy treatment to fight bladder cancer

(Source – news.va.gov) An Army Veteran from Houston received a dose of optimism when he came in for a groundbreaking

Aging Alzheimer's/Dementia FDA Part D/Prescription Drugs

Eileen Cook January 11, 2024January 11, 2024 Alzheimer's Disease, beta amyloid plaques, blood test, Dementia, FDA, Lecanemab Drug, Older Adults

Blood tests can help diagnose Alzheimer’s — if they’re accurate enough. Not all are

(By Jon Hamilton for NPR) A new generation of blood tests is poised to change the way doctors determine whether

FDA Medical Technology

Eileen Cook December 21, 2023December 21, 2023 FDA, Medical devices, patient safety

Deep Flaws in FDA Oversight of Medical Devices, and Patient Harm, Exposed in Lawsuits and Records

(By Fred Schulte and Holly K. Hacker for KFF Health News) Living with diabetes, Carlton “PeeWee” Gautney Jr. relied on

End of Life FDA Medical Technology

Eileen Cook December 19, 2023December 19, 2023 Courts, FDA, Medical devices, Older Adults, patient safety

Patients Facing Death Are Opting for a Lifesaving Heart Device — But at What Risk?

(By Daniel Chang and Holly K. Hacker for KFF Health News) Too old and too sick for a heart transplant,

FDA Health Care Finance Legal Actions/Court Decisions Legislative Update Part D/Prescription Drugs

Eileen Cook December 8, 2023December 8, 2023 Bayh-Dole Act of 1980, Biomedical research, Healthcare Costs, March In Rights, Medicare Part D, Prescription drug costs, Prescription Drug Patents

White House proposes to ‘march in’ on patents for costly drugs

(By Sydney Lupkin for NPR) The Biden administration is taking another crack at high prescription drug prices. This time its

FDA Legislative Update Part D/Prescription Drugs

Eileen Cook December 7, 2023December 7, 2023 Drug Imports, Drugmakers, FDA, Medicare Part D

Colorado Blames Biden Team and Drugmakers for Delaying Canadian Imports

(By Phil Galewitz for KFF Health News) Colorado officials say their plan to import cheaper medicines from Canada has been

Aging FDA Legal Actions/Court Decisions Medical Technology

Eileen Cook December 5, 2023 Artificial Hips, FDA, Healthcare Costs, Medical Technology, Older Adults

Patients Expected Profemur Artificial Hips to Last. Then They Snapped in Half.

(By Brett Kelman and Anna Werner, CBS News and KFF Health News) Bradley Little, a physical education teacher in Arizona,

Alzheimer's/Dementia FDA Medicare - General Part D/Prescription Drugs

Eileen Cook November 28, 2023November 28, 2023 Aducanumab, Alzheimer's Disease, ARIA, CMS, Dementia, Donanemab, FDA, Lecanemab Drug, medicare, Medicare Part D, Older Adults

Manufacturers need to be more open about a dangerous Alzheimer’s drug side effect

(By Madhav Thambisetty for STAT) Since the FDA’s approval of lecanemab (marketed as Leqembi) and Medicare’s recent decision to cover

FDA Health Care Finance National Institutes of Health Part D/Prescription Drugs

Eileen Cook November 17, 2023 Drug Companies, Drug costs, Drug Research, Healthcare Costs, Medicare Part D, National Institutes of Health

Sen. Sanders pushes NIH to rein in drug prices

(By Sydney Lupkin for NPR) Can the National Institutes of Health bring down drug prices? It doesn’t approve new medicines

Aging Alzheimer's/Dementia FDA Medical Technology

Eileen Cook October 26, 2023 AD-Detect, Alzheimer's Disease, Medical Technology, Older Adults

Doubts Abound About a New Alzheimer’s Blood Test

(By Judith Graham for KFF Health News) For the first time, people worried about their risk of Alzheimer’s disease can